Home Clinical Trial Updates

Clinical Trial Updates

Electromagnetic Navigation Bronchoscopy Shows Positive Response In Lung Cancer Study

An analysis of 12-month results from NAVIGATE, the largest, prospective, multicenter trial designed to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using Medtronic's...

Study Confirms Complication Rates and Costs for Drugs and Diagnostics Higher...

According to a new study from The University of Texas MD Anderson Cancer Center, complication rates following invasive diagnostic procedures for lung abnormalities were...

INmune Bio Receives Phase I Clinical Trial Authorization for Lead Product...

INmune Bio, a clinical-stage biotechnology company developing anti-cancer therapies to reprogram the innate immune system to fight disease, has received Clinical Trial Authorization (CTA)...

Rakuten Aspyrian Raises US $284 Million Series C Financing; Develops Photoimmunotherapy...

Privately funded clinical stage biotechnology company Rakuten Aspyrian has raised an additional $134 million in a second tranche of its Series C financing, bringing...

Daiichi Sankyo Initiates Phase I Study to Evaluate the Combination Quizartinib...

A first patient has been dosed in the first novel-novel combination phase I study evaluating two investigational agents being developed by Daiichi Sankyo. The phase...

Phase III ARCHES Trial Shows Positive Results for Enzalutamide in Prostate...

Despite improved treatment options for patients progressing on standard hormone treatment, metastatic prostate cancer still remains a deadly disease. For men with metastatic hormone-sensitive prostate...

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

Daiichi Sankyo and AnHeart Therapeutics, a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of innovative medicines, have entered into a worldwide...

Phase III AGENT Trial Enrolls First Metastatic Colorectal Cancer Patient

A first patient has been enrolled in the pivotal Phase III AGENT clinical study designed to evaluate arfolitixorin (Modufolin®; Isofol Medical) for the treatment...

Oxybutynin Improved Quality of Life for Breast Cancer Survivors

Treatment with oxybutynin chloride (Ditropan XL®; Janssen Pharmaceuticals) helped reduce the frequency and intensity of hot flashes for women who could not take hormone...

Type of Surgery May affect Health Related Quality of Life for...

Results from a study funded by the Agency for Healthcare Research and Quality, Susan G. Komen, the Breast Cancer Research Foundation, and The Pink...

Latest